NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novo Nordisk A/S's accounts payable for the three months ended in Sep. 2014 was $509 Mil. Novo Nordisk A/S's cost of goods sold for the three months ended in Sep. 2014 was $583 Mil. Hence, Novo Nordisk A/S's days accounts payable for the three months ended in Sep. 2014 was 79.58.
Novo Nordisk A/S's days accounts payable increased from Sep. 2013 (75.87) to Sep. 2014 (79.58). It may suggest that Novo Nordisk A/S delayed paying its suppliers.
Days Accounts Payable indicates the number of days that the accounts payable relative to cost of goods sold the company has. An increase of Days Accounts Payable may suggest that the company delays paying its suppliers.
Novo Nordisk A/S's Days Accounts Payable for the fiscal year that ended in Dec. 2013 is calculated as
Novo Nordisk A/S's Days Accounts Payable for the quarter that ended in Sep. 2014 is calculated as:
|Days Accounts Payable||=||Accounts Payable||/||COGS||*||Days in Period|
|=||508.829589769||/||583.417059755||*||365 / 4|
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Novo Nordisk A/S Annual Data
|Days Accts Payable||48.19||59.75||65.17||72.54||82.29||78.40||90.81||95.42||104.61||105.63|
Novo Nordisk A/S Quarterly Data
|Days Accts Payable||70.41||70.41||111.68||77.85||73.41||75.87||109.82||91.88||74.27||79.58|